The delisting threat is removed for now, but the company still carries a large accumulated deficit ($649.9M) and the preferred stock carries a 19.5% cumulative dividend. Watch for the next quarterly filing to confirm continued compliance and monitor any further tranche issuances under the $70M facility. The warrants (PIIIW) benefit from the survival, but common equity faces ongoing dilution.
Price Chart
Executive Summary
P3 Health Partners resolved its Nasdaq delisting threat by exchanging ~$252.5M of debt for preferred stock and raising $30M via Series D preferred units, boosting stockholders' equity from ($143.5M) to $82.1M. The company believes it has regained compliance with Listing Rule 5550(b)(1), though Nasdaq will continue to monitor. The rescue financing eliminates near-term survival risk but adds dilutive, high-cost preferred stock.
Key Facts
- Debt exchange of approximately $252.5M of promissory notes for non-convertible preferred stock with $100 stated value.
- Securities Purchase Agreement for up to $70M of Series D 19.5% Cumulative Preferred Stock units; $30M sold initially.
- Pro forma stockholders' equity improved from ($143.5M) to $82.1M.
- Debt exchange reduced long-term debt by ~$195.7M (from $259.6M to $63.9M).
- Nasdaq extension to regain compliance expired May 20, 2026; company believes it now satisfies the $2.5M equity minimum.
Financial Impact
Debt reduction of ~$195.7M and cash infusion of $30M, eliminating immediate delisting risk. Stockholders' equity turned positive by $225.7M.
Risk Factors
- Nasdaq may require evidence of compliance at next periodic report; failure could restart delisting process.
- Series D preferred dividends (19.5% cumulative) add fixed charges to a money-losing operation.
- Additional $40M of Series D units could be issued, further diluting common and warrant holders.
- Company still has significant negative retained earnings and may need further capital.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001832511-26-000024 |
| Document: piii-20260514.htm | 0001832511-26-000024 |
| Document: 0001832511-26-000024-index-headers.html | 0001832511-26-000024 |
| Document: 0001832511-26-000024-index.html | 0001832511-26-000024 |
| Document: 0001832511-26-000024.txt | 0001832511-26-000024 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 15, 2026 23w ago | 8-K | $0.006500 $0.0188 | ▲ +189.23% | ▲ +184.38% | — |
Apr 28, 2026 25w ago | 8-K | $0.006500 $0.0128 | ▼ −96.92% | ▼ −92.81% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers